Abstract
A summary of the First Signature Series Event, “Advancements in Cellular Therapies
and Regenerative Medicine for Digestive Diseases,” held on May 3, 2017, in London,
United Kingdom, is presented. Twelve speakers from three continents covered major
topics in the areas of cellular therapy and regenerative medicine applied to liver
and gastrointestinal medicine as well as to diabetes mellitus. Highlights from their
presentations, together with an overview of the global impact of digestive diseases
and a proposal for a shared online collection and data-monitoring platform tool, are
included in this proceedings. Although growing evidence demonstrate the feasibility
and safety of exploiting cell-based technologies for the treatment of digestive diseases,
regulatory and methodological obstacles will need to be overcome before the successful
implementation in the clinic of these novel attractive therapeutic strategies.
Key Words
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to CytotherapyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013.Lancet. 2015; 386: 743-800
- The global burden of IBD: from 2015 to 2025.Nat Rev Gastroenterol Hepatol. 2015; 12: 720-727
- The prevalence of celiac disease in Europe: results of a centralized, international mass screening project.Ann Med. 2010; 42: 587-595
- Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study.J Hepatol. 2014; 60: 612-617
- Prevalence and incidence of autoimmune pancreatitis in the population living in the Southwest of Germany.Digestion. 2017; 96: 187-198
- Incidence trends of Type 1 and Type 2 diabetes among youths, 2002–2012.N Engl J Med. 2017; 377: 301https://doi.org/10.1056/NEJMc1706291
- Trends in overall and cause-specific mortality among patients with inflammatory bowel disease from 1982 to 2010.Clin Gastroenterol Hepatol. 2013; 11: 43-48
- Preclinical disease and preventive strategies in IBD: perspectives, challenges and opportunities.Gut. 2016; 65: 1061-1069
- Liver cirrhosis.Lancet. 2008; 371: 838-851
- The organ transplant imperative.Mayo Clin Proc. 2017; 92: 940-946
- Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.Cell. 2006; 126: 663-676
- Direct reprogramming of human fibroblasts to functional and expandable hepatocytes.Cell Stem Cell. 2014; 14: 370-384
- Human hepatocytes with drug metabolic function induced from fibroblasts by lineage reprogramming.Cell Stem Cell. 2014; 14: 394-403
- Direct reprogramming of hepatic myofibroblasts into hepatocytes in vivo attenuates liver fibrosis.Cell Stem Cell. 2016; 18: 797-808
- Development of adenoviral delivery systems to target hepatic stellate cells in vivo.PLoS ONE. 2013; 8 (e67091)
- A novel murine model to deplete hepatic stellate cells uncovers their role in amplifying liver damage in mice.Hepatology. 2013; 57: 339-350
- Concise review: clinical programs of stem cell therapies for liver and pancreas.Stem Cells. 2013; 31: 2047-2060
- Human fetal liver-derived stem cell transplantation as supportive modality in the management of end-stage decompensated liver cirrhosis.Cell Transplant. 2010; 19: 409-418
- Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London.Cell Transplant. 2012; 21: 1-10
- Successful transplantation of human hepatic stem cells with restricted localization to liver using hyaluronan grafts.Hepatology. 2013; 57: 775-784
- Hyaluronan coating improves liver engraftment of transplanted human biliary tree stem/progenitor cells.Stem Cell Res Ther. 2017; 8: 68https://doi.org/10.1186/s13287-017-0492-7
- Cryopreservation protocol for human biliary tree stem/progenitors, hepatic and pancreatic precursors.Sci Rep. 2017; 7: 6080https://doi.org/10.1038/s41598-017-05858-0
- Bone marrow as a potential source of hepatic oval cells.Science. 1999; 284: 1168-1170
- Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation.Hepatology. 2000; 31: 235-240
- Purified hematopoietic stem cells can differentiate into hepatocytes in vivo.Nat Med. 2000; 6: 1229-1234
- Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice.Hepatology. 2004; 40: 1304-1311
- G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs.Exp Hematol. 2005; 33: 108-119
- Bone marrow cell transplant does not prevent or reverse murine liver cirrhosis.Cell Transplant. 2008; 17: 943-953
- Mesenchymal stromal cells and liver fibrosis: a complicated relationship.FASEB J. 2016; 30: 3905-3928
- Systemic infusion of FLK1(+) mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice.Transplantation. 2004; 78: 83-88
- The bone marrow functionally contributes to liver fibrosis.Gastroenterology. 2006; 130: 1807-1821
- A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis.Gastroenterology. 2004; 126: 955-963
- Hematopoietic origin of hepatic stellate cells in the adult liver.Blood. 2008; 111: 2427-2435
- Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice.Gastroenterology. 2009; 137 (e1): 1459-1466https://doi.org/10.1053/j.gastro.2009.07.006
- Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology.Nat Commun. 2013; 4: 2823https://doi.org/10.1038/ncomms3823
- Systematic review: the effects of autologous stem cell therapy for patients with liver disease.Aliment Pharmacol Ther. 2014; 39: 673-685
- Cellular therapy for liver disease.Mayo Clin Proc. 2014; 89: 414-424
- REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial.BMJ Open. 2015; 5: e007700https://doi.org/10.1136/bmjopen-2015-007700
- Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study.Liver Int. 2014; 34: 33-41
- Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes.Hepatology. 2011; 54: 820-828
- Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis: Egyptian study.Clin Transplant. 2013; 27: 607-612
- The model for end-stage liver disease (MELD).Hepatology. 2007; 45: 797-805
- Discarded livers find a new life: engineered liver grafts using hepatocytes recovered from marginal livers.Artif Organs. 2017; 41: 579-585
- Nondestructive methods for monitoring cell removal during rat liver decellularization.Tissue Eng Part C Meth. 2016; 22: 671-678
- Layer-by-layer heparinization of decellularized liver matrices to reduce thrombogenicity of recellularized liver grafts.J Clin Transl Res. 2015; : 1-9https://doi.org/10.18053/jctres.201501.004
- Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds.Annu Rev Biomed Eng. 2011; 13: 27-53
- Organ bioengineering and regeneration as the new Holy Grail for organ transplantation.Ann Surg. 2013; 258: 221-232
- Engineered whole organs and complex tissues.Lancet. 2012; 379: 943-952
- Experimental evaluation of kidney regeneration by organ scaffold recellularization.Sci Rep. 2017; 7: 43502https://doi.org/10.1038/srep43502
- Rapid production of human liver scaffolds for functional tissue engineering by high shear stress oscillation-decellularization.Sci Rep. 2017; 7: 5534https://doi.org/10.1038/s41598-017-05134-1
- Guidelines for the management of inflammatory bowel disease in adults.Gut. 2011; 60: 571-607
- Crohn's disease.Lancet. 2012; 380: 1590-1605
- Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses.Gastroenterology. 2009; 136: 978-989
- Human adipose-derived stem cells attenuate inflammatory bowel disease in IL-10 knockout mice.Tissue Cell. 2015; 47: 86-93
- Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.Gut. 2010; 59: 1662-1669
- Allogeneic mesenchymal stem cell transplantation in seven patients with refractory inflammatory bowel disease.Gut. 2012; 61: 468-469
- Safety and tolerability of humanplacenta-derived cells (PDA001) in treatment-resistant crohn's disease: a phase 1 study.Inflamm Bowel Dis. 2013; 19: 754-760
- A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy.Clin Gastroenterol Hepatol. 2014; 12: 64-71
- Fate of intravenously injected mesenchymal stem cells and significance for clinical application.Adv Biochem Eng Biotechnol. 2013; 130: 19-37
- Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs).J Cell Mol Med. 2010; 14: 2190-2199
- Human kidney-derived cells ameliorate acute kidney injury without engrafting into renal tissue.Stem Cells Transl Med. 2017; 6: 1373-1384
- Mesenchymal stromal cells modulate macrophages in clinically relevant lung injury models by extracellular vesicle mitochondrial transfer.Am J Respir Crit Care Med. 2017; https://doi.org/10.1164/rccm.201701-0170OC
- Mesenchymal stem cells-derived extracellular vesicles, via miR-210, improve infarcted cardiac function by promotion of angiogenesis.Biochim Biophys Acta. 2017; 1863: 2085-2092
- Effect of the microenvironment on mesenchymal stem cell paracrine signaling: opportunities to engineer the therapeutic effect.Stem Cells Dev. 2017; 26: 617-631
- Mesenchymal stem cells reduce colitis in mice via release of TSG6, independently of their localization to the intestine.Gastroenterology. 2015; 149: 163-176
- Mesenchymal stem cell effects on T-cell effector pathways.Stem Cell Res Ther. 2011; 2: 34https://doi.org/10.1186/scrt75
- Mesenchymal cells recruit and regulate T regulatory cells.Exp Hematol. 2008; 36: 309-318
- Mucosally transplanted mesenchymal stem cells stimulate intestinal healing by promoting angiogenesis.J Clin Invest. 2015; 125: 3606-3618
- Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy.Front Physiol. 2012; 3: 359https://doi.org/10.3389/fphys.2012.00359
- Exosomes: vehicles of intercellular signaling, biomarkers, and vectors of cell therapy.Annu Rev Physiol. 2015; 77: 13-27
- The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles.Proteomics. 2013; 13: 1637-1653
- Immunomodulatory potential of human adipose mesenchymal stem cells derived exosomes on in vitro stimulated T cells.Front Immunol. 2014; 5: 556https://doi.org/10.3389/fimmu.2014.00556
- Mesenchymal stem cell-derived microvesicles protect against acute tubular injury.J Am Soc Nephrol. 2009; 20: 1053-1067
- Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension.Circulation. 2012; 126: 2601-2611
- Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury.Stem Cell Res. 2010; 4: 214-222
- Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications.Mol Ther. 2015; 23: 812-823
- Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial.Lancet. 2016; 388: 1281-1290
- The clinical course of fistulating Crohn's disease.Alim Pharmacol Ther. 2003; 17: 1145-1151
- The spectrum of perianal Crohn's disease in a population-based cohort.Dis Colon Rectum. 2012; 55: 773-777
- Disappointing durable remission rates in complex Crohn's disease fistula.Inflamm Bowel Dis. 2014; 20: 2022-2028
- Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial.Dis Colon Rectum. 2009; 52: 79-86
- Autologous bone marrow–derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease.Gut. 2011; 60: 788-798
- Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial.Int J Colorectal Dis. 2013; 28: 313-323
- Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn's fistula.Stem Cells. 2013; 31: 2575-2581
- Autologous adipose tissue-derived stem cells for the treatment of Crohn's fistula: a phase I clinical study.Cell Transplant. 2013; 22: 279-285
- Allogeneic bone marrow-serived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with Crohn's disease.Gastroenterology. 2015; 149: 918-927
- Allogeneic adipose-derived stem cells for the treatment of perianal fistula in Crohn's disease: a pilot clinical trial.Colorectal Dis. 2015; 18: 468-476
- Treatment of Crohn's-related rectovaginal fistula with allogeneic expanded-adipose derived stem cells: a phase I–IIa clinical trial.Stem Cell Transl Med. 2016; 5: 1441-1446
- Autologous mesenchymal stem cells, applied in a bioabsorbable matrix, for treatment of perianal fistulas in patients with Crohn's disease.Gastroenterology. 2017; 153: 59-62
- A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease.Gut. 2014; 63: 1381-1392
- Long-term results of adipose-derived stem cell therapy for the treatment of Crohn's fistula.Stem Cells Transl Med. 2015; 4: 532-537
- Long-term follow-up of Crohn disease fistulas after local injections of bone marrow–derived mesenchymal stem cells.Mayo Clin Proc. 2015; 90: 747-755
- Epidemiology of esophageal atresia.Dis Esophagus. 2013; 26: 354-355
- The first tissue-engineered airway transplantation: 5-year follow-up results.Lancet. 2014; 383: 238-244
- Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study.Lancet. 2012; 380: 994-1000
- Trachea transplants test the limits.Science. 2013; 340: 266-268
- A rat decellularized small bowel scaffold that preserves villus-crypt architetcure for intestinal regeneration.Biomaterials. 2012; 33: 3401-3410
- Association of insulin pump therapy vs insulin injection therapy with severe hypoglycemia, ketoacidosis, and glycemic control among children, adolescents, and young adults with type 1 diabetes.JAMA. 2017; 318: 1358-1366
- Pancreas transplantation for type 2 diabetes mellitus.Curr Opin Organ Transplant. 2011; 16: 110-115
- Clinical results of islet transplantation.Pharmacol Res. 2015; 98: 86-91
- Five-year metabolic, functional, and safety results of patients with type 1 diabetes transplanted with allogenic islets within the Swiss-French GRAGIL network.Diabetes Care. 2015; 38: 1714-1722
- Long-term outcome after pancreas transplantation: a registry analysis.Curr Opin Organ Transplant. 2016; 21: 377-385
- Pancreas after islet transplantation: a first report of the International Pancreas Transplant Registry.Am J Transplant. 2016; 16: 688-693
- Islet product characteristics and factors related to successful human islet transplantation from the Collaborative Islet Transplant Registry (CITR) 1999–2010.Am J Transplant. 2014; 14: 2595-2606
- Report from IPITA-TTS opinion leaders meeting on the future of beta-cell replacement.Transplantation. 2016; 100: S1-44
- The state of the art of islet transplantation and cell therapy in type 1 diabetes.Acta Diabetol. 2016; 53: 683-691
- The resurgence of xenotransplantation.Am J Transplant. 2017; 17: 2531-2536
- Genetic modification of pigs as organ donors for xenotransplantation.Mol Reprod Dev. 2010; 77: 209-221
- Inactivation of porcine endogenous retrovirus in pigs using CRISPR-Cas9.Science. 2017; 357: 1303-1307
- Glycoprotein 2 is a specific cell surface marker of human pancreatic progenitors.Nat Commun. 2017; 8: 331https://doi.org/10.1038/s41467-017-00561-0
- Development of an encapsulated stem cell-based therapy for diabetes.Exp Opin Biol Ther. 2015; 15: 1321-1336
- Fibrin gels engineered with pro-angiogenic growth factors promote engraftment of pancreatic islets in extrahepatic sites in mice.Biotechnol Bioeng. 2015; 112: 1916-1926
- Effects of composition of alginate-polyethylene glycol microcapsules and transplant site on encapsulated islet graft outcomes in mice.Transplantation. 2017; 101: 1025-1035
- Device design and materials optimization of conformal coating for islets of Langerhans.Proc Natl Acad Sci USA. 2014; 111: 10514-10519
- Immunoisolation of murine islet allografts in vascularized sites through conformal coating with polyethylene glycol.Am J Transplant. 2017; https://doi.org/10.1111/ajt.14547
- Nano-sized drug-loaded micelles deliver payload to lymph node immune cells and prolong allograft survival.J Control Release. 2011; 156: 154-160
- Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support.J Biomed Inf. 2009; 42: 377-381
Article info
Publication history
Published online: February 04, 2018
Accepted:
December 1,
2017
Received:
November 25,
2017
Identification
Copyright
© 2017 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.
